Zanosar

Zanosar (streptozocin) is an intravenous chemotherapy medication used primarily for pancreatic cancer. This alkylating agent works by slowing or stopping cancer cell growth. Always consult a healthcare provider for personalized guidance.

Zanosar is a chemotherapy drug prescribed for treating pancreatic cancer, particularly islet cell carcinoma. It may also be used in research settings for other conditions. Patients often ask, 'What is streptozocin used for?' and it is primarily indicated for specific cancer treatments.

Zanosar works by interfering with the growth of cancer cells in the body. Common effects include nausea, vomiting, and fatigue during treatment. Some patients may experience changes in kidney function or blood cell counts.

Zanosar should only be administered by healthcare professionals in a controlled setting. Patients should inform their doctor about all medications and medical conditions before starting treatment. Regular monitoring of kidney function and blood counts is typically required.

Zanosar may interact with other medications, including certain antibiotics, antivirals, and immunosuppressants. Alcohol and other substances that affect the liver or kidneys should be avoided. Always disclose all medications to your healthcare provider.